# Bevacizumab

## Avastin inj 100mg/4mL

| 藥物代碼           | IAVA                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | In combination with irinotecan/5-fluorouracil/leucovorin or 5-fluorouracil/leucovorin as 1st-line treatment of metastatic carcinoma of the colon or rectum                                                                                                                                                                                             |
| 副作用             | Asthenia, pain, abdominal pain, headache, hypertension, diarrhea, nausea, vomiting, anorexia, stomatitis, constipation, upper respiratory infection, epistaxis, dyspnea, exfoliative dermatitis, proteinuria. Rarely, GI perforation, hemorrhage, arterial thromboembolism, wound healing complications, hypertensive crises, nephrotic syndrome, CHF. |
| 禁忌               | Hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanised antibodies; untreated CNS metastases.                                                                                                                                                                                                                  |
| 藥物保存方式       | 2-8 C                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量           | 5 mg/ kg IV over 90 min every 2 weeks; rate may be increased with subsequent doses.                                                                                                                                                                                                                                                                    |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                           |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                         |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest moderate risk                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                   |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                    |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                    |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                    |
| 輸注點滴液         | 【N/S】 可選                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                    |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                    |
| 注意事項           | 1. 輸注溶液不可含葡萄糖。 2. 稀釋後輸注溶液應擺放於2-8度C儲存，超過8小時未使用應丟棄。 3. 第一次使用建議施打90分鐘，之後視病人耐受程度可縮短輸注時間至30-60分鐘。 4. 監測蛋白尿。 5. 每2-3週監測血壓變化。                                                                                                                                             |

